NCT03359785View on ClinicalTrials.gov

A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions
Schizophrenia
Interventions
DRUG

Luvadaxistat

TAK-831 Tablets.

DRUG

Matching Placebo

Matching Placebo Tablets.

Trial Locations (1)

20877

CBH Health, LLC, Gaithersburg

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Neurocrine Biosciences

INDUSTRY